A new role for opioids in the treatment of arthritis

Drugs

Volumn 62, Issue 2, 2002, Pages 255-263

  Roth, Sanford H ^a  

^a Arizona Research and Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DIHYDROMORPHINE; IBUPROFEN; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL;

ADDICTION; ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTHRITIS; CHRONIC PAIN; CONSTIPATION; DROWSINESS; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERANCE; DYSPHORIA; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFORMED CONSENT; NAUSEA; NOCICEPTION; PATHOPHYSIOLOGY; RESPIRATION DEPRESSION; REVIEW;

EID: 0036180834     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262020-00002     Document Type: Review

References (65)

1. Nonsteroidal anti-inflammatory drug gastropathy: Recognition and response
2. Nonsteroidal anti-inflammatory drug gastropathy: We started-can we stop it?
3. Nonsteroidal anti-inflammatory drug associated gastropathy: Incidence and risk factor models
4. CSM update: Nonsteroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions to
5. Gastrointestinal tract complications of nonsteroid anti-inflammatory drug treatment in rheumatoid arthritis: A prospective observational cohort study
6. NSAID gastropathy: A new understanding
7. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
8. Doubts raised on the safety of two popular arthritis drugs
9. Selective COX-2 specific inhibitors and cardiorenal function: A randomized control trial of celecoxib and refecoxib in older hypertensive osteoarthritis patients
10. Who's pain is it anyhow?
11. Salicylates
12. Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia
13. Painful neuropathy: Altered central processing maintained dynamically by peripheral input
14. Central pain: 'New' syndromes and evaluation
15. The experience of chronic nonmalignant pain
16. Recommendations for the medical management of osteoarthritis of the hip and knee 2002 update. American college of rheumatology subcommittee on osteoarthritis guidelines
17. The role of opioids in the treatment of osteoarthritis
18. Opioids and rheumatic disease pain
19. Selection of analgesic therapies in rheumatoid arthritis: The role of opioid medications
20. Opioid therapy for osteoarthritis of the hip and knee: Use it or lose it?
21. Opioid therapy for chronic nonmalignant pain
22. Pain management and chemical dependency. Evolving perspective
23. ADL 8-2698, A trans-3,4-dimethyl-4-3(3-hydroxylphenyl) piperidine, prevents gastrointestinal effects of i.v. morphine without affecting analgesia
24. Opioid analgesics and antagonists
25. The OxyContin underground
26. Around the clock controlled release oxycodone therapy for arthritis related pain; placebo controlled trial and long term evaluation
27. Treatment of osteoarthritis pain with controlled released oxycodone of fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: A double-blind randomized multicenter placebo controlled trial
28. Efficacy and safety of controlled release versus immediate release oxycodone: Randomized double bund evaluation on patients with chronic back pain
29. A randomized trial of controlled release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty
30. Relative potency of controlled release oxycodone and controlled released morphine in a postoperative pain model
31. The relative potency between high dose oxycodone and intervenous morphine
32. Codeine and oxycodone use in patients with chronic rheumatic disease pain
33. Efficacy of ultram (tramadol HCL) treatment of fibromyalgia syndrome: Preliminary analysis of a multicenter randomized placebo controlled study
34. Finessing fibromyalgia
35. Efficacy and safety of tramadol HCL in breakthrough musculoskeletal pain attributed to osteoarthritis
36. Tramadol verus dextropropoxyphene in the treatment of osteoarthritis. A short term double-blind study
37. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol
38. Comparison of tramadol and acetaminophen with codeine for long term pain management in elderly patients
39. Tramadol allows reduction of naproxen dose among patients with naproxen responsive osteoarthritis pain
40. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute and chronic pain states
41. Transdermal fentanyl. A review of its pharmacological and therapeutic efficacy in pain control
42. Coupling of sympathetic and somatosensory neurons following nerve injury: Mechanisms and potential significance for the generation of pain
43. Chronic opioid therapy in nonmalignant pain
44. Comparative study of tilidine-naloxone and pentazocine in knee and hip osteoarthritis int
45. The efficacy and tolerability of controlled release dihydrocodeine tablets in combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips
46. Acceptability and efficacy of two association of paracetamol with a central analgesic (dextropropoxyphene or codeine): Comparison in osteoarthritis
47. Comparative effectiveness of five analgesics with patients with rheumatoid arthritis and osteoarthritis
48. Comparison of a standard ibuprofen treatment with a new ibuprofen/paracetamol/codeine combination in chronic osteoarthritis
49. Codeine plus paracetamol versus paracetamol in longer term treatment of chronic pain due to osteoarthritis of the hip. A randomized double-blind multicenter study
50. American Geriatrics Society panel on chronic pain in older persons. The management of chronic pain in older persons
51. Prescription opioid abuse in chronic pain patients: Clinical criteria incidence and predictors
52. Drug abuse, dependence and addiction in chronic pain patients
53. Addiction rare in patients treated with narcotics
54. Opioid use in the treatment of chronic pain: Assessment of addiction
55. A review of the effects of opioids on psychomotor and cognitive functioning in humans
56. Guidelines for managing chronic nonmalignant pain. Opioids and other agents
57. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and American Pain Society
58. Opioid analgesic drugs in the elderly
59. The management of chronic pain in older patients. AGS panel on chronic pain in older patients
60. A drug use evaluation of selected opioid and non-opioid analgesics in a nursing facility setting
61. A double-blind comparison of meptazinol versus placebo in chronic rheumatoid arthritis and osteoarthritis
62. Ibuprofen plus codeine, ibuprofen, and placebo in a single and a multidose crossover comparison for coxarthrosis pain
63. Double-blind randomized placebo controlled trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee